These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 3358644

  • 21. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [Abstract] [Full Text] [Related]

  • 22. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989 Nov; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 23. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Overview of the Cross-National Collaborative Panic Study.
    Klerman GL.
    Arch Gen Psychiatry; 1988 May; 45(5):407-12. PubMed ID: 3282477
    [Abstract] [Full Text] [Related]

  • 26. Alprazolam in the treatment of social phobia.
    Lydiard RB, Laraia MT, Howell EF, Ballenger JC.
    J Clin Psychiatry; 1988 Jan; 49(1):17-9. PubMed ID: 3335485
    [Abstract] [Full Text] [Related]

  • 27. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W, Noyes R.
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [Abstract] [Full Text] [Related]

  • 28. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC.
    J Psychiatr Res; 1993 Nov; 27 Suppl 1():155-70. PubMed ID: 8145176
    [Abstract] [Full Text] [Related]

  • 29. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR, Perel JM.
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [Abstract] [Full Text] [Related]

  • 30. Placebo response in panic disorder.
    Coryell W, Noyes R.
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [Abstract] [Full Text] [Related]

  • 31. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [Abstract] [Full Text] [Related]

  • 32. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Nagy LM, Krystal JH, Woods SW, Charney DS.
    Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
    Mavissakalian M, Perel J, Bowler K, Dealy R.
    Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Alprazolam treatment for panic disorders.
    Alexander PE, Alexander DD.
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [Abstract] [Full Text] [Related]

  • 37. Response of panic disorder to fixed doses of alprazolam or imipramine.
    Uhlenhuth EH, Matuzas W, Glass RM, Easton C.
    J Affect Disord; 1989 Jun; 17(3):261-70. PubMed ID: 2529295
    [Abstract] [Full Text] [Related]

  • 38. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome.
    Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H.
    Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 Nov; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 40. Fading of therapeutic effects of alprazolam in agoraphobia. Case reports.
    Fava GA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Nov; 12(1):109-12. PubMed ID: 3363164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.